Lipella pharmaceuticals reports positive topline phase 2a results for lp-310 in the treatment of oral lichen planus

Pittsburgh, feb. 11, 2025 – prism mediawire – lipella pharmaceuticals inc.
LIPO Ratings Summary
LIPO Quant Ranking